Schonfeld Strategic Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $547K | Buy |
60,000
+20,000
| +50% | +$182K | ﹤0.01% | 1431 |
|
2025
Q1 | $318K | Buy |
+40,000
| New | +$318K | ﹤0.01% | 1636 |
|
2024
Q4 | – | Sell |
-121,316
| Closed | -$876K | – | 2196 |
|
2024
Q3 | $876K | Buy |
121,316
+52,564
| +76% | +$380K | 0.01% | 1073 |
|
2024
Q2 | $747K | Buy |
+68,752
| New | +$747K | ﹤0.01% | 1202 |
|
2024
Q1 | – | Sell |
-20,992
| Closed | -$455K | – | 2145 |
|
2023
Q4 | $455K | Sell |
20,992
-108,427
| -84% | -$2.35M | ﹤0.01% | 1239 |
|
2023
Q3 | $2.66M | Buy |
129,419
+108,596
| +522% | +$2.23M | 0.02% | 633 |
|
2023
Q2 | $979K | Buy |
+20,823
| New | +$979K | 0.01% | 969 |
|
2023
Q1 | – | Sell |
-14,872
| Closed | -$567K | – | 2472 |
|
2022
Q4 | $567K | Buy |
14,872
+5,668
| +62% | +$216K | ﹤0.01% | 1445 |
|
2022
Q3 | $360K | Buy |
+9,204
| New | +$360K | ﹤0.01% | 1933 |
|
2022
Q2 | – | Sell |
-16,680
| Closed | -$552K | – | 2819 |
|
2022
Q1 | $552K | Buy |
+16,680
| New | +$552K | 0.01% | 1240 |
|
2021
Q2 | – | Sell |
-15,333
| Closed | -$1.15M | – | 2196 |
|
2021
Q1 | $1.15M | Buy |
+15,333
| New | +$1.15M | 0.01% | 804 |
|
2020
Q3 | – | Sell |
-20,050
| Closed | -$834K | – | 1561 |
|
2020
Q2 | $834K | Buy |
20,050
+12,381
| +161% | +$515K | 0.02% | 621 |
|
2020
Q1 | $220K | Buy |
7,669
+4,111
| +116% | +$118K | 0.01% | 879 |
|
2019
Q4 | $257K | Sell |
3,558
-12,842
| -78% | -$928K | 0.01% | 1053 |
|
2019
Q3 | $2.3M | Buy |
+16,400
| New | +$2.3M | 0.07% | 284 |
|
2018
Q4 | – | Sell |
-8,900
| Closed | -$1.26M | – | 1209 |
|
2018
Q3 | $1.26M | Buy |
+8,900
| New | +$1.26M | 0.06% | 382 |
|
2017
Q3 | – | Sell |
-8,586
| Closed | -$684K | – | 735 |
|
2017
Q2 | $684K | Buy |
+8,586
| New | +$684K | 0.07% | 340 |
|
2016
Q4 | – | Sell |
-30,567
| Closed | -$1.41M | – | 638 |
|
2016
Q3 | $1.41M | Buy |
30,567
+20,567
| +206% | +$947K | 0.24% | 116 |
|
2016
Q2 | $301K | Sell |
10,000
-1,419
| -12% | -$42.7K | 0.07% | 315 |
|
2016
Q1 | $366K | Buy |
+11,419
| New | +$366K | 0.15% | 183 |
|